实施药物基因组学知识以推进精准医疗的证据与资源
本文描述了药物基因组学数据整理与传播的现状,并综述了将药物基因组学数据应用于临床实践的证据资源。尽管科学进展显著,但临床实施较慢,主要障碍包括缺乏将基因检测结果转化为临床行动的知识,以及证据阈值选择的争议。CPIC和PharmGKB等组织系统评估证据并发布基于证据的用药推荐,其在线资源对实施药物基因组学至关重要。
要点
- CPIC和PharmGKB提供在线资源,辅助解读基因检测结果并给出特定基因-药物对的用药推荐。
- 药物基因组学临床实施慢的原因包括缺乏转化知识和证据阈值争议。
- 大型随机对照试验难以或不被认为必要来确立药物基因组学检测的临床效用。
核心结论
- CPIC和PharmGKB等组织采用标准化方法评估文献并为越来越多的基因-药物对提供临床指导,这些资源对将药物基因组学实施到常规临床实践至关重要。
研究设计与样本
- 本文为综述,描述了药物基因组学数据整理与传播的现状,并综述了应用于临床实践的证据资源。
主要发现
- 尽管在理解遗传变异与药物反应变异性关联方面科学进展显著,但药物基因组学在临床实践中的实施相对缓慢。
- 抑制采用遗传数据指导用药的因素包括缺乏基于现有证据将基因检测结果转化为临床行动的知识。
- 其他实施挑战包括关于选择适当证据阈值以常规临床实施药物基因组学数据的争议,以及汇编科学数据支持临床推荐的困难。
关键数值与推荐
- CPIC和PharmGKB系统评估药物基因组学关联的新兴证据,并发布基于证据的处方推荐以指导临床实践。
- CPIC和PharmGKB均提供在线资源,便于解读基因检测结果并提供特定基因-药物对的处方推荐。
临床怎么用
- 临床药师可利用CPIC和PharmGKB的在线资源解读基因检测结果,并获取特定基因-药物对的处方推荐以指导用药决策。
局限性
- 大型随机对照试验证明药物基因组学检测效用不可行或不被认为必要,导致支持临床推荐的证据汇编困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The current state of pharmacogenetic data curation and dissemination is described, and evidence-based resources for applying pharmacogenetic data in clinical practice are reviewed. SUMMARY: Implementation of pharmacogenetics in clinical practice has been relatively slow despite substantial scientific progress in understanding linkages between genetic variation and variability of drug response and effect. One factor that has inhibited the adoption of genetic data to guide medication use is a lack of knowledge of how to translate genetic test results into clinical action based on currently available evidence. Other implementation challenges include controversy over selection of appropriate evidentiary thresholds for routine clinical implementation of pharmacogenetic data and the difficulty of compiling scientific data to support clinical recommendations given that large randomized controlled trials to demonstrate the utility of pharmacogenetic testing are not feasible or are not considered necessary to establish clinical utility. Organizations such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Pharmacogenomics Knowledgebase (PharmGKB) systematically evaluate emerging evidence of pharmacogenomic linkages and publish evidence-based prescribing recommendations to inform clinical practice. Both CPIC and PharmGKB provide online resources that facilitate the interpretation of genetic test results and provide prescribing recommendations for specific gene-drug pairs. CONCLUSION: Resources provided by organizations such as CPIC and PharmGKB, which use standardized approaches to evaluate the literature and provide clinical guidance for a growing number of gene-drug pairs, are essential for the implementation of pharmacogenetics into routine clinical practice.
引用
- Caudle KE, Gammal RS, Whirl-Carrillo M, et al. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Am J Health Syst Pharm. 2016. PMID: 27864205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。